Characteristics of patients with neovascular age-related macular degeneration who are non-responders to intravitreal aflibercept.

Intravitreal aflibercept is effective for treating eye pathology in most naïve AMD cases. However, non-responsiveness may occur in small subgroup of patients with choroidal vascular hyperpermeability.